BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2019
View Archived Issues
High-throughput, low-stress analysis method separates out brain cells
Read More
Prostate cancer cell lineage switch identified
Read More
Procarta Biosystems announces funding for development of new class of antibiotic precision medicines
Read More
CROI 2019: KSHV targeting may move from lytic to latent phase
Read More
Sf3b1 gene mutation with Atm gene deletion yields new model of chronic lymphocytic leukemia
Read More
Phase III studies of triple combination of VX-445, tezacaftor and ivacaftor meet primary endpoint
Read More
Santen launches two new research and development projects selected for the CiCLE program
Read More
Transgene plans clinical development of individualized immunotherapy TG-4050
Read More
FDA approves IND for phase I trials of NK cell adoptive immunotherapy candidate SNK-01
Read More
Intarcia opts to inlicense ND-016 from Numab Therapeutics
Read More
Novel selective inhibitor of the RUVBL1/2 complex demonstrates anticancer activity in vivo
Read More
VU-6012962 results in decreased anxiety response in preclinical models
Read More
I-Mab Biopharma begins phase Ib/IIa study of TJ-107 in China
Read More
Acesion Pharma divulges SK3 blockers
Read More
XW Laboratories discloses ROS production inhibitors
Read More
JAK and/or SYK kinase inhibitors disclosed by Beijing Hanmi Pharmaceutical
Read More
Zhejiang Hisun Pharmaceutical describes KIT and PDGFR-alpha mutant inhibitors
Read More
Bifunctional TFR1 ligand-peptides as erythroblast-targeted gene therapy for erythroid disorders
Read More
SHR-A1403 antibody-drug conjugate, a potential therapy for cancers with c-Met overexpression
Read More
Combined use of DREP-based vectors and MVA-HCV as promising vaccines against HCV
Read More
Chinese researchers patent 5-HT1A receptor agonists
Read More
Glycopeptide derivative of angiotensin-(1-7) reverses cognitive dysfunction in mice models of VCID
Read More
DS Biopharma reports promising data on DS-107 cream in moderate to severe atopic dermatitis
Read More
Three pivotal studies of rapastinel in adjunctive treatment of MDD miss primary endpoint
Read More
Completion of phase Ia study of FOR-6219 for endometriosis paves way for phase Ib
Read More
Immutep reports new data from phase I TACTI-mel study of eftilagimod alpha in melanoma
Read More
